Discover and read the best of Twitter Threads about #PeregineWatchlist
Most recents (5)
1) $LGND on #PeregineWatchlist . . . already nibbling.
Last Earnings 3 Feb 21 BMO
Profit: $1.42 per share
+43.43% eBEAT
+29.00% rBEAT
Earnings Growth: +178.22% yoy
Revenue Growth: +159.20% yoy
Last Earnings 3 Feb 21 BMO
Profit: $1.42 per share
+43.43% eBEAT
+29.00% rBEAT
Earnings Growth: +178.22% yoy
Revenue Growth: +159.20% yoy
2) 3911 Sorrento Valley Boulevard, Suite 110
San Diego, California
ligand.com
Sector: Health Care
Industry: Biotechnology
Employees: 115
San Diego, California
ligand.com
Sector: Health Care
Industry: Biotechnology
Employees: 115
3) DESCRIPTION
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines.
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines.
1) Looking pretty on this gap up breakout today. Was on #PeregrineWatchlist, now moving to #PeregineWatchlist.
First earnings for the Nasdaq IPO today after the market closes. Already a PROFITABLE company.
First earnings for the Nasdaq IPO today after the market closes. Already a PROFITABLE company.
2) Latest news: 9 analysts just initiated coverage today. All of them have higher price targets than current price of $21.62.
Aug-31-20InitiatedRBC Capital MktsOutperform$29
Aug-31-20InitiatedJP MorganOverweight$28
Aug-31-20InitiatedGoldmanBuy$44
(continued)
Aug-31-20InitiatedRBC Capital MktsOutperform$29
Aug-31-20InitiatedJP MorganOverweight$28
Aug-31-20InitiatedGoldmanBuy$44
(continued)
3) More initiating coverages for with price targets:
Aug-31-20InitiatedEvercore ISIOutperform$24
Aug-31-20InitiatedDeutsche BankBuy$26
Aug-31-20InitiatedCredit SuisseOutperform$27
Aug-31-20InitiatedCitigroupBuy$24
(continued)
Aug-31-20InitiatedEvercore ISIOutperform$24
Aug-31-20InitiatedDeutsche BankBuy$26
Aug-31-20InitiatedCredit SuisseOutperform$27
Aug-31-20InitiatedCitigroupBuy$24
(continued)
1) reminds me of which I sold today and in which I kept gains as FREE shares.
Both biotechs had profitable earnings & revenue BEATs.
Both had monstrous revenue growth. And both flopped post earnings instead of gapping up.
#PeregineWatchlist #PeregrineBreakout
Both biotechs had profitable earnings & revenue BEATs.
Both had monstrous revenue growth. And both flopped post earnings instead of gapping up.
#PeregineWatchlist #PeregrineBreakout
2) last earnings was post-market, Mon, 3 Aug 20
+24.67% eBEAT
+19.43% rBEAT
+64.7% rGrowth
+24.67% eBEAT
+19.43% rBEAT
+64.7% rGrowth
3) Neurocrine Biosciences, Inc.
12780 El Camino Real
San Diego, California
neurocrine.com
Sector: Health Care
Industry: Biotechnology
Employees: 700
12780 El Camino Real
San Diego, California
neurocrine.com
Sector: Health Care
Industry: Biotechnology
Employees: 700
1) Last night, I added the airline sector etf to #PeregineWatchlist again. I already have a stash of free shares aquired from a winning trade in this symbol. I like the threatening bullish breakout here because of looks at individual airline stocks. 6 charts follow:
2) Alaska Airlines, regional carrier out West, is one I own free shares in also from prefious winning trade where I keep gains in underlying shares. This airline is very strict on COVID protocols. Will be layng off some folks next month:
3) American Airlines looks very close to breaking out too like
1) MercadoLibre just killed estimates by longshots.
MercadoLibre huge beats on earnings and revenues estimates. Revenue growth of 61.1% yoy
MercadoLibre huge beats on earnings and revenues estimates. Revenue growth of 61.1% yoy
2) For now, just read this on . . . finance.yahoo.com/news/mercadoli…
